Based on Clinical Research Matrix Metalloprotease (MMP) Inhibitors to Promote Diabetic Wound Healing

Abstract

Chronic inflammation is a common factor in obesity, diabetes mellitus, and the complications of diabetes, including diabetic wounds. These ulcers are characterized by persistent lesions that are challenging to heal, significantly decreasing patients’ quality of life and imposing a substantial financial burden on society. MMP are zinc endopeptidases that play a role in wound healing in response to various stimuli, including diabetes mellitus. MMP levels fluctuate throughout the wound healing process in diabetic patients' serum, skin tissues, and wound fluid, indicating their potential as biomarkers for diabetic foot ulcers. Targeting MMP has emerged as a promising strategy for treating diabetic wounds, as these enzymes are involved in critical biological processes related to wound healing, including extracellular matrix secretion, angiogenesis, granulation tissue formation, collagen growth, re-epithelization, inflammatory response, and oxidative stress.

Key words

MMPs - diabetic wound - NF-kB - FOXO-1 - stem cells

• References

• 1 Whiting DR, Guariguata L, Weil C. et al. IDF Diabetes Atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011; 94: 311-321
• 2 Yadav JP, Grishina M, Shahbaaz M. et al. Cucumis melo var. momordica as a potent antidiabetic, antioxidant and possible anticovid alternative: investigation through experimental and computational methods. Chem Biodivers 2022; 19: e202200200
• 3 Vijayakumar V, Samal SK, Mohanty S. et al. Recent advancements in biopolymer and metal nanoparticle-based materials in diabetic wound healing management. Int J Biol Macromol 2019; 122: 137-148
• 4 Sinwar PD. The diabetic foot management - recent advance. Int J Surg 2015; 15: 27-30
• 5 Yadav JP, Patel DK, Pathak P. et al. Role of G-protein coupled receptor (GPCRs)/(GPR-120) as an agonists in diabetic wound healing. Obes Med 2022; 36: 100466
• 6 Cho H, Blatchley MR, Duh EJ. et al. Acellular and cellular approaches to improve diabetic wound healing. Adv Drug Deliv Rev 2019; 146: 267-288
• 7 Yadav JP, Patel DK, Dubey NK. et al. Wound healing and antioxidant potential of Neolamarckia cadamba in streptozotocin-nicotinamide induced diabetic rats. Phytomedicine Plus 2022; 2: 100274
• 8 Lobmann R, Zemlin C, Motzkau M. et al. Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with a protease absorbent dressing. J Diabetes Complicat 2006; 20: 329-335
• 9 Demidova-Rice TN, Hamblin MR, Herman IM. Acute and impaired wound healing: pathophysiology and current methods for drug delivery, part 1: normal and chronic wounds: biology, causes and approaches to care. Adv Ski Wound Care 2012; 25: 349-370
• 10 auf dem Keller U, Sabino F. Matrix metalloproteinases in impaired wound healing. Met Med 2015; 9: 1-8
• 11 Cabral-Pacheco GA, Garza-Veloz I, Castruita-De la Rosa C. et al. The roles of matrix metalloproteinases and their inhibitors in human diseases. Int J Mol Sci 2020; 21: 1-53
• 12 Lobmann R, Ambrosch A, Schultz G. et al. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 2002; 45: 1011-1016
• 13 Arpino V, Brock M, Gill SE. The role of TIMPs in regulation of extracellular matrix proteolysis. Matrix Biol 2015; 44–46: 247-254
• 14 Chang M, Nguyen TT. Strategy for treatment of infected diabetic foot ulcers. Acc Chem Res 2021; 54: 1080-1093
• 15 Zhou L, Ren M, Zeng T. et al. TET2-interacting long noncoding RNA promotes active DNA demethylation of the MMP-9 promoter in diabetic wound healing. Cell Death Dis 2019; 10: 813
• 16 Hu H, Jiang H, Ren H. et al. AGEs and chronic subclinical inflammation in diabetes: disorders of immune system. Diabetes Metab Res Rev 2015; 31: 127-137
• 17 De Mayo T, Conget P, Becerra-Bayona S. et al. The role of bone marrow mesenchymal stromal cell derivatives in skin wound healing in diabetic mice. PLoS One 2017; 12: 1-17
• 18 Zhu P, Chen C, Wu D. et al. AGEs-induced MMP-9 activation mediated by Notch1 signaling is involved in impaired wound healing in diabetic rats. Diabetes Res Clin Pract 2022; 186: 1-5
• 19 Zhu P, Ren M, Yang C. et al. Involvement of RAGE, MAPK and NF-κB pathways in AGEs-induced MMP-9 activation in HaCaT keratinocytes. Exp Dermatol 2012; 21: 123-129
• 20 Huang SM, Wu CS, Chiu MH. et al. High glucose environment induces M1 macrophage polarization that impairs keratinocyte migration via TNF-α: An important mechanism to delay the diabetic wound healing. J Dermatol Sci 2019; 96: 159-167
• 21 Wang Y, Graves DT. Keratinocyte function in normal and diabetic wounds and modulation by FoxO1. J Diabetes Res 2020; 3714704
• 22 Hameedaldeen A, Liu J, Batres A. et al. FOXO1, TGF-β regulation and wound healing. Int J Mol Sci 2014; 15: 16257-16269
• 23 Patel S, Srivastava S, Singh MR. et al. Biomedicine & pharmacotherapy mechanistic insight into diabetic wounds: pathogenesis , molecular targets and treatment strategies to pace wound healing. Biomed Pharmacother 2019; 112: 108615
• 24 Zhang C, Lim J, Jeon HH. et al. FOXO1 deletion in keratinocytes improves diabetic wound healing through MMP9 regulation. Sci Rep 2017; 7: 1-9
• 25 Xu J, Zgheib C, Hodges MM. et al. Mesenchymal stem cells correct impaired diabetic wound healing by decreasing ECM proteolysis. Physiol Genomics 2017; 49: 541-548
• 26 Gadelkarim M, Abushouk AI, Ghanem E. et al. Adipose-derived stem cells: Effectiveness and advances in delivery in diabetic wound healing. Biomed Pharmacother 2018; 107: 625-633
• 27 Zhang N, Yu X, Li W. et al. Extracellular vesicles derived from adipose-derived stem cells facilitate frostbite wound healing by regulating SOCS3 expression. Curr Stem Cell Res Ther 2022; 18: 528-539
• 28 Kato J, Kamiya H, Himeno T. et al. Mesenchymal stem cells ameliorate impaired wound healing through enhancing keratinocyte functions in diabetic foot ulcerations on the plantar skin of rats. J Diabetes Complicat 2014; 28: 588-595
• 29 Lv Y, Ge LH, Zhao YM. Effect and mechanism of SHED on ulcer wound healing in Sprague-Dawley rat models with diabetic ulcer. Am J Transl Res 2017; 9: 489-498
• 30 Balaji S, Han N, Moles C. et al. Angiopoietin-1 improves endothelial progenitor cell-dependent neovascularization in diabetic wounds. Surg (United States) 2015; 158: 846-856
• 31 Deng L, Du C, Song P. et al. The role of oxidative stress and antioxidants in diabetic wound healing. Oxid Med Cell Longev 2021; 2021: 1-11
• 32 Gao M, Nguyen TT, Suckow MA. et al. Acceleration of diabetic wound healing using a novel proteaseanti-protease combination therapy. Proc Natl Acad Sci U S A 2015; 112: 15226-15231
• 33 Wu X, He W, Mu X. et al. Macrophage polarization in diabetic wound healing. Burns & Trauma 2022; 10: tkac051
• 34 Yadav JP, Singh AK, Grishina M. et al. Cucumis melo Var. agrestis Naudin as a potent antidiabetic: Investigation via experimental methods. Phytomed Plus 2022; 2: 100340
• 35 Ling L, Ren M, Yang C. et al. Role of site-specific DNA demethylation in TNFα -induced MMP9 expression in keratinocytes. Soc Endocrinol 2013; 50: 279-290
• 36 Lu W, Li J, Ren M. et al. Role of the mevalonate pathway in specific CpG site demethylation on AGEs-induced MMP9 expression and activation in keratinocytes. Mol Cell Endocrinol 2015; 411: 121-129
• 37 Zhang J, Yang C, Wang C. et al. AGE-induced keratinocyte MMP-9 expression is linked to TET2-mediated CpG demethylation. Wound Rep Reg 2016; 24: 489-500
• 38 Jindatanmanusan P, Luanraksa S, Boonsiri T. et al. Wound fluid matrix metalloproteinase-9 as a potential predictive marker for the poor healing outcome in diabetic foot ulcers. Patholog Res Int 2018; 2018: 1-5
• 39 Liu Y, Min D, Bolton T. et al. Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers. Diabetes Care 2009; 32: 117-119
• 40 Singh K, Agrawal NK, Gupta SK. et al. A functional single nucleotide polymorphism -1562c>t in the matrix metalloproteinase-9 promoter is associated with type 2 diabetes and diabetic foot ulcers. Int J Low Extrem Wounds 2013; 12: 199-204
• 41 Trøstrup H, Holstein P, Karlsmark T. et al. Uncontrolled gelatin degradation in non-healing chronic wounds. J Wound Care 2018; 27: 724-734
• 42 Dinh T, Tecilazich F, Kafanas A. et al. Mechanisms involved in the development and healing of diabetic foot ulceration. Diabetes 2012; 61: 2937-2947
• 43 Li G, Zou X, Zhu Y. et al. Expression and influence of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 and vascular endothelial growth factor in diabetic foot ulcers. Int J Low Extrem Wounds 2017; 16: 6-13
• 44 Menghini R, Uccioli L, Vainieri E. et al. Expression of tissue inhibitor of metalloprotease 3 is reduced in ischemic but not neuropathic ulcers from patients with type 2 diabetes mellitus. Acta diabetologica 2013; 50: 907-910
• 45 Min D, Nube V, Tao A. et al. Monocyte phenotype as a predictive marker for wound healing in diabetes-related foot ulcers. J Diabetes Complicat 2021; 35: 107889
• 46 Kupczyk D, Bilski R, Studzińska R. et al. Assessment of the concentration of selected metalloproteinases (MMP-2, MMP-3, MMP-9 and MMP-13) in patients with ulcers as a complication of type 2 diabetes. Adv Dermatol Allergol 2020; 39: 59-65
• 47 Nguyen TT, Ding D, Wolter WR. et al. Validation of matrix metalloproteinase-9 ( MMP-9 ) as a novel target for treatment of diabetic foot ulcers in humans and discovery of a potent and selective small-molecule MMP-9 inhibitor that accelerates healing. J Med Chem 2018; 61: 8825-8837
• 48 Hilton JR, Williams DT, Beuker B. et al. Wound dressings in diabetic foot disease 2004; 39: 14-17
• 49 Hiller J, Stratmann B, Timm J. et al. Enhanced growth factor expression in chronic diabetic wounds treated by cold atmospheric plasma. Diabet Med 2022; 39: e14787
• 50 Rayment EA, Dargaville TR, Shooter GK. et al. Attenuation of protease activity in chronic wound fluid with bisphosphonate-functionalised hydrogels. Biomaterials 2008; 29: 1785-1795